Search

Your search keyword '"Tristan de Nattes"' showing total 16 results
Start Over Author "Tristan de Nattes"
16 results on '"Tristan de Nattes"'

1. Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose

Author

Dominique Bertrand, Charlotte Laurent, Mathilde Lemoine, Ludivine Lebourg, Mélanie Hanoy, Frank Le Roy, Dorian Nezam, Diana Pruteanu, Steven Grange, Tristan De Nattes, Véronique Lemée, Dominique Guerrot, and Sophie Candon

Subjects
belatacept, kidney transplantation, COVID-19, cellular immune response, ELISPOT, Biology (General), QH301-705.5
Abstract

Monoclonal antibodies have been administered to kidney transplant recipients (KTRs) with a poor or non-responder status to SARS-CoV-2 vaccination. The cellular response to SARS-CoV-2 has been poorly studied in this context. We assessed the T cell response to SARS-CoV-2 in 97 patients on the day of the injection of tixagevimab/cilgavimab using an IFNγ enzyme-linked immunospot assay (ELISPOT). Among the 97 patients, 34 (35%) developed COVID-19 before the injection. Twenty-nine (85.3%) had an ELISPOT compatible with a SARS-CoV-2 infection. There was no difference between KTRs under belatacept or tacrolimus treatment. Sixty-three patients (64.9%) had no known COVID-19 prior to the ELISPOT, but nine (14.3%) had a positive ELISPOT. In 21 KTRs with a positive ELISPOT who received a booster dose of a bivalent mRNA vaccine, median antibody titers and spike-reactive T cells increased significantly in patients under tacrolimus but not belatacept. Our study emphasizes the potential usefulness of the exploration of immune cellular response to SARS-CoV-2 by ELISPOT. In KTRs with a positive ELISPOT and under CNI therapy, a booster dose of mRNA vaccine seems effective in inducing an immune response to SARS-CoV-2.

Published
2024
Full Text
View/download PDF

2. Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series

Author

Tristan de Nattes, Lucile Moreau-Grangé, Delphine Vezzosi, Julien Hadoux, Miguel Hie, Dominique Guerrot, and Steven Grangé

Subjects
Thrombotic microangiopathy, Hemolytic uremic syndrome, Acute kidney injury, Adrenocortical carcinoma, Diseases of the genitourinary system. Urology, RC870-923
Abstract

Abstract Background Cancer-related thrombotic microangiopathy (CR-TMA) is a rare entity associated with a dismal prognosis. Usually, CR-TMA is associated with mucin-producing carcinomas among which stomach, breast, prostate, lung and pancreas tumours are the most frequent. Cases presentation We describe for the first time three cases of CR-TMA due to adrenocortical carcinoma (ACC). All of them had mechanical hemolytic anemia and thrombocytopenia without any other identifiable cause. Bicytopenia was diagnosed either simultaneously with ACC or at the time of metastatic evolution. Two patients had acute kidney injury (AKI) with severe pathological findings on kidney biopsy. Despite total adrenalectomy, chemotherapy, and specific treatment of TMA with plasma-exchanges, renal failure and hemolytic anemia remained. The only manifestation of CR-TMA in the third patient was hemolytic anemia, which resolved after surgical removal of ACC. The evolutions in these patients suggests ACC-related TMA may be related to a circulating factor. Conclusions CR-TMAs are rare. Here we describe the first case series of ACC-related TMA, among which two had renal involvement. This entity is associated with dismal renal prognosis despite specific treatment of TMA. According to patients’ evolution, the persistence of TMA may reflect an uncontrolled malignancy.

Published
2020
Full Text
View/download PDF

3. Hemolysis induced by Left Ventricular Assist Device is associated with proximal tubulopathy.

Author

Tristan de Nattes, Pierre-Yves Litzler, Arnaud Gay, Catherine Nafeh-Bizet, Arnaud François, and Dominique Guerrot

Subjects
Medicine, Science
Abstract

BackgroundChronic subclinical hemolysis is frequent in patients implanted with Left Ventricular Assist Device (LVAD) and is associated with adverse outcomes. Consequences of LVADs-induced subclinical hemolysis on kidney structure and function is currently unknown.MethodsThirty-three patients implanted with a Heartmate II LVAD (Abbott, Inc, Chicago IL) were retrospectively studied. Hemolysis, Acute Kidney Injury (AKI) and the evolution of estimated Glomerular Filtration Rate were analyzed. Proximal Tubulopathy (PT) groups were defined according to proteinuria, normoglycemic glycosuria, and electrolytic disorders. The Receiver Operating Characteristic (ROC) curve was used to analyze threshold of LDH values associated with PT.ResultsMedian LDH between PT groups were statistically different, 688 IU/L [642-703] and 356 IU/L [320-494] in the "PT" and "no PT" groups, respectively p = 0.006. To determine PT group, LDH threshold > 600 IU/L was associated with a sensitivity of 85.7% (95% CI, 42.1-99.6) and a specificity of 84.6% (95% CI, 65.1-95.6). The ROC's Area Under Curve was 0.83 (95% CI, 0.68-0.98). In the "PT" group, patients had 4.2 [2.5-5.0] AKI episodes per year of exposure, versus 1.6 [0.4-3.7] in the "no PT" group, p = 0.03. A higher occurrence of AKI was associated with subsequent development of Chronic Kidney Disease (CKD) (p = 0.02) and death (p = 0.05).ConclusionsLVADs-induced subclinical hemolysis is associated with proximal tubular functional alterations, which in turn contribute to the occurrence of AKI and subsequent CKD. Owing to renal toxicity of hemolysis, measures to reduce subclinical hemolysis intensity as canula position or pump parameters should be systematically considered, as well as specific nephroprotective therapies.

Published
2020
Full Text
View/download PDF

4. Correction to: Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series

Author

Tristan de Nattes, Lucile Moreau-Grangé, Delphine Vezzosi, Julien Hadoux, Miguel Hie, Dominique Guerrot, and Steven Grangé

Subjects
Diseases of the genitourinary system. Urology, RC870-923
Abstract

Following publication of the original article [1], we have been notified that the name of one author was spelled incorrectly as Julien Haddoux, when the correct spelling is Julien Hadoux.

Published
2020
Full Text
View/download PDF

7. CD86 occupancy in belatacept-treated kidney transplant patients is not associated with clinical and infectious outcomes

Author

Tristan de Nattes, Ludivine Lebourg, Isabelle Etienne, Charlotte Laurent, Mathilde Lemoine, Audrey Dumont, Dominique Guerrot, Serge Jacquot, Sophie Candon, and Dominique Bertrand

Subjects
Abatacept, Graft Rejection, Transplantation, Humans, Immunology and Allergy, Pharmacology (medical), Kidney Transplantation, Antibodies, Immunosuppressive Agents
Abstract

The CD86 occupancy assay has been developed to measure the number of CD86 molecules unbound to belatacept, but its association with clinical outcomes has not been assessed yet. All kidney transplant patients switched to belatacept in our center between 2016 and 2018 were included. Blood samples were collected before each infusion for 1 year to assess CD86 occupancy by CD86 antibody cytometry staining on the surface of CD14

Published
2022
Full Text
View/download PDF

8. Kidney Transplant T Cell–Mediated Rejection Occurring After Anti-CD19 CAR T-Cell Therapy for Refractory Aggressive Burkitt-like Lymphoma With 11q Aberration: A Case Report

Author

Dominique Guerrot, Florence Morin, Sophie Candon, Mathilde Lemoine, Catherine Thieblemont, Dominique Bertrand, Grégoire Dallet, Arnaud François, Vincent Camus, Elena-Liana Veresezan, Christophe Ferrand, Jean-Baptiste Latouche, and Tristan de Nattes

Subjects
Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, T cell, Salvage therapy, medicine.disease, Gastroenterology, Lymphoma, Transplantation, medicine.anatomical_structure, Nephrology, Internal medicine, Medicine, Onconephrology, Arteritis, business, Kidney transplantation
Abstract

Post-transplant lymphoproliferative disorder is a growing complication of kidney transplantation and is associated with a poor prognosis. Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy is an important new treatment option modifying the outcome of refractory hematological cancers. Here, we report the case of a 40-year-old kidney transplant recipient who developed a Burkitt-like lymphoma with 11q aberration 5 years after transplantation. After 3 unsuccessful lines of chemotherapy, it was decided to treat the patient with anti-CD19 CAR T cells as a salvage therapy. Three months after CAR T-cell infusion, she experienced a grade IIB T cell-mediated rejection with severe tubulitis (T3), slight interstitial inflammation (I1), and severe intimal arteritis (V2) with blood suffusion. Among T cells infiltrating the graft, some of them expressed the anti-CD19 CAR. CAR T cells within the graft and in blood samples were also detected by droplet digital polymerase chain reaction. Function of the kidney transplant improved after corticosteroid treatment and remained stable. However, lymphoma progressed, with a massive pulmonary mass leading to the patient's death 10 months after CAR T-cell infusion.

Published
2022
Full Text
View/download PDF

10. Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years

Author

Sophie Candon, Tristan de Nattes, Isabelle Etienne, Johan Noble, Charlotte Laurent, Marie Matignon, Dominique Bertrand, Antoine Morel, Dominique Guerrot, Martin Planchais, and Arnaud François

Subjects
Graft Rejection, Nephrology, medicine.medical_specialty, Chronic Active, business.industry, Calcineurin Inhibitors, Graft Survival, Urology, Renal function, Kidney, medicine.disease, Kidney Transplantation, Belatacept, Kidney transplant, Abatacept, Calcineurin, Chronic allograft nephropathy, Internal medicine, Antibody mediated rejection, medicine, Humans, business, Immunosuppressive Agents, medicine.drug
Published
2021
Full Text
View/download PDF

11. Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score 2): a retrospective cohort study

Author

Dominique Bertrand, Marie Matignon, Antoine Morel, Lebourg Ludivine, Mathilde Lemoine, Mélanie Hanoy, Frank Le Roy, Dorian Nezam, Mouad Hamzaoui, Tristan de Nattes, Anissa Moktefi, Arnaud François, Charlotte Laurent, Isabelle Etienne, and Dominique Guerrot

Subjects
Transplantation, Nephrology
Abstract

Background Immunosuppression in kidney transplant recipients with decreased graft function and histological vascular changes can be particularly challenging. The impact of a late rescue conversion to belatacept on kidney graft survival in this context has never been studied. Methods We report a bicentric retrospective cohort study comparing a calcineurin inhibitor (CNI) to belatacept switch versus CNI continuation in 139 kidney transplant recipients with histological kidney vascular damage (cv ≥2, g + cpt ≤1, i + t ≤1) and low estimated glomerular filtration rate (≤40 mL/min/1.73 m²). Primary outcome was death-censored graft survival. Results During the study follow-up, 10 graft losses (14.5%) occurred in the belatacept group (n = 69) versus 26 (37.1%) in the matched CNI group (n = 70) (P = .005). Death-censored graft survival was significantly higher in the belatacept group (P = .001). At 3 years, graft survival was 84.0% in the belatacept group compared with 65.1% in the control group. Continuing CNI was an independent risk factor for graft loss [hazard ratio (HR) 3.46; P Conclusion The replacement of CNI with belatacept in patients with decreased allograft function and vascular lesions is associated with an improvement in graft survival and represents a valuable option in a context of organ shortage. Caution should be exercised regarding the increased risk of opportunistic infection.

Published
2022

12. Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients

Author

Dominique Bertrand, Charlotte Laurent, Veronique Lemée, Ludivine Lebourg, Mélanie Hanoy, Frank Le Roy, Dorian Nezam, Diana Pruteanu, Steven Grange, Tristan de Nattes, Mathilde Lemoine, Sophie Candon, and Dominique Guerrot

Subjects
Nephrology, SARS-CoV-2, Vaccination, Antibodies, Monoclonal, COVID-19, Humans, Antibodies, Viral, Kidney Transplantation, Transplant Recipients
Published
2022

13. [Nephrology 2.0: Communication with connected patients and health professionals]

Author

Dominique, Guerrot, Tristan, de Nattes, Antoine, Lanot, and Marc, Hazzan

Subjects
Nephrologists, Nephrology, Communication, Humans, Social Media, Social Networking
Abstract

Web 2.0 is characterized by the development of the Internet from its initial static content to a dynamic and participatory content, and by the large place taken by social networks. The growing interest of health actors for information and communication via these new media is gradually but lastingly modifying the practice of nephrology. These developments require nephrologists to understand the issues, rules and risks associated with these digital tools. The present article summarizes the main practical aspects of communication with patients and health professionals and addresses the important issue of the digital identity of the caregiver in the new field of connected nephrology.

Published
2022

14. Lesson for the clinical nephrologist: immune monitoring of human JC-polyomavirus in kidney transplantation

Author

Sophie Candon, Emmanuel Gerardin, Tristan de Nattes, Dominique Bertrand, and Isabelle Etienne

Subjects
Nephrology, medicine.medical_specialty, Polyomavirus Infections, business.industry, Progressive multifocal leukoencephalopathy, Urology, Immune monitoring, medicine.disease, Kidney transplant, Belatacept, JC Virus, Kidney Transplantation, Nephrologists, Monitoring, Immunologic, Internal medicine, Medicine, Humans, business, Kidney transplantation, medicine.drug
Published
2021

15. Retinal Arteriolar Occlusions and Exudative Retinal Detachments in Malignant Hypertension: More Than Meets the Eye

Author

Cédric Rafat, Yosu Luque, Michel Pâques, Tristan de Nattes, Rana Saad, David Buob, Alice Doreille, Charles Verney, Laurent Mesnard, Urgences néphrologiques et transplantation rénale [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université - Faculté de Médecine (SU FM), Sorbonne Université (SU), CHU Rouen, Normandie Université (NU), Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (CHNO), Institut Hospitalo-Universitaire FOReSIGHT, Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (CHNO)-Sorbonne Université (SU), Service de Pathologie [CHU Tenon], Gestionnaire, Hal Sorbonne Université, Service d'Urgences néphrologiques et transplantation rénale [CHU Tenon], CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)

Subjects
Male, Retinal Artery Occlusion, [SDV]Life Sciences [q-bio], Posterior pole, 030204 cardiovascular system & hematology, Hypertension, Malignant, chemistry.chemical_compound, 0302 clinical medicine, retinal wall-to-lumen ratio, malignant hypertension, Papilledema, Correlation of Data, retinal arteriolar occlusion, medicine.diagnostic_test, Incidence, blood pressure, Exudative retinal detachment, optic disc swelling, Middle Aged, 3. Good health, [SDV] Life Sciences [q-bio], Arterioles, acute kidney injury, Female, Kidney Diseases, France, medicine.symptom, exudative retinal detachment, medicine.medical_specialty, hypertension, Retina, Ophthalmoscopy, 03 medical and health sciences, Branch retinal artery occlusion, Ophthalmology, Internal Medicine, medicine, Humans, business.industry, Retinal Detachment, Retinal Vessels, Retinal, Blood Pressure Determination, medicine.disease, Juxtaglomerular Apparatus, Blood pressure, chemistry, Retinal arteriolar occlusion, 030221 ophthalmology & optometry, business
Abstract

BACKGROUND Malignant hypertension is macrovascular and microvascular endothelial injury responsible for multiple organ damage. Considering the anatomical and functional homologies between the posterior pole of the eye and the kidney, ophthalmological explorations may inform clinicians on the mechanisms underpinning concurrent kidney injury in this condition. More specifically, we investigated whether the wall-to-lumen ratio (WLR) of retinal arterioles measured by adaptive optics ophthalmoscopy could be correlated to WLR of kidney arterioles as determined by pathology. We sought to estimate the incidence of retinal arteriole occlusion a supposedly uncommon complication of malignant hypertension. METHODS All patients hospitalized in our renal Intensive Care Unit for malignant hypertension between 2016 and 2019 were referred to ophthalmological examinations. RESULTS Twenty-seven patients were included. Median retinal WLR was 0.39 [0.31–0.47] and was correlated with initial systolic (r = 0.56, P = 0.003) and mean blood pressure (r = 0.46, P = 0.02) upon admission. The retinal WLR was not correlated to renal pathological findings, as assessed by juxtaglomerular WLR (r = 0.38, P = 0.2), ratio of glomerulosclerosis (r = −0.39, P = 0.2), or tubulointerstitial fibrosis (r = −0.45, P = 0.08). Retinal WLR was not associated with neurological or cardiovascular end-organ damage. Branch retinal artery occlusion was detected in 18.5% of patients and exudative retinal detachment (ERD) in 29.6% of patients, without any significant correlation with canonical signs of retinal hypertension including optic disc swelling. CONCLUSIONS In the setting of malignant hypertension, we failed to demonstrate a significant relationship between WLR and other meaningful end-organ injuries. However, branch retinal artery occlusion and ERD may have been hitherto underestimated.

Published
2021
Full Text
View/download PDF

16. Auteurs

Author

Laetitia, Amalou, Cédric, Annweiler, Élise, Artaud-Macari, Alexis, Arvin-Bérod, Patrick, Assayag, Maria, Bailleul, Emma, Bajeux, Grégory, Baptista, Martine, Barateau, Bernard, Bauduceau, Laetitia, Beernaert, Joël, Belmin, Athanase, Bénétos, Michel, Benoit, Hubert, Blain, Sylva, Blazkova, Wanda, Blervaque, Sylvie, Bonin-Guillaume, Mylène, Bonnaire, Marc, Bonnefoy, Mathilde, Bordage, Lyse, Bordier, Chokri, Boubakri, Didier, Bouccara, Anne-Sophie, Boureau, Bruneau, Marie-Andrée, Pierre-Emmanuel, Cailleaux, Priscille, Carvalho, Philippe, Chassagne, Aline, Corvol, Matthieu, Coulongeat, Antoine, Cuvelier, Sandra, De Breucker, Laure, De Decker, Tristan, De Nattes, Amandine, Dessertennes, Audrey, De Vos, Benoît, de Wazières, Frédéric, Di Fiore, Aurélien, Dinh, Cristiano, Donadio, Jean-Michel, Dorey, Jean, Doucet, Olivier, Drunat, Feriel, Fennira, Claire, Falandry, Juliette, Fontaine, Thibaut, Fraisse, Patrick, Friocourt, Tamàs, Fülöp, Julien, Gaudric, Jean-Bernard, Gauvain, Gaëtan, Gavazzi, Xavier, Gbaguidi, Charles-Emmanuel, Geffroy, Christian, Geny, Édouard, Georgeton, Baptiste, Gérard, Angélique, Giacomini, Mathilde, Gisselbrecht, Alice, Gochard-Rodrigues, Bernard, Goichot, Régis, Gonthier, Odile, Goria, Adrien, Grancher, Béatrice, Guérin, Dominique, Guerrot, Olivier, Hanon, Charlotte, Havreng-Théry, Réjean, Hébert, Mathieu, Herrmann, Patrick, Hidoux, Jérémie, Huet, Witold, Jarzebowski, Olivier, Jeanjean, Georges, Kaltenbach, Alain, Koskas, Pierre, Krolak-Salmon, Carmelo, Lafuente-Lafuente, Pierre-Olivier, Lang, Martine, Le Noc Soudani, Amandine, Lecarpentier, Laurent, Lechowski, Pierre-Olivier, Lefebvre, Anne, Léger, Caroline, Lemaitre, Thierry, Lequerré, Anaïs, Lesourd, Pierre, Lutzler, Arach, Madjlessi, Éric, Maeker, Emmanuel, Maheu, Patrick, Manckoundia, Nathalie, Maubourguet, Sylvie, Meaume, Anne, Michel, Boubacar, Mohamed, Hélène, Montialoux, Sophie, Moulias, France, Mourey, Stéphane, Nacache, Sylvain, N'Guyen, Charlotte, Nouhaud, Jean-Luc, Novella, Christel, Oasi, Marine, Olivieri, Bruno, Oquendo, Mourad, Ould Slimane, Marc, Paccalin, Elena, Paillaud, Frédéric, Pamoukdjian, Sylvie, Pariel, Erika, Parmentier-Decrucq, Christine, Perret-Guillaume, Mélissa-Asli, Petit, François, Pinoche, Julien, Poissy, Valérie, Pouysségur, Isabelle, Prêcheur, Alain, Putot, Yasmine, Rassam-Hasso, Agathe, Raynaud-Simon, Clothilde, Riquier, Frédéric, Roca, Jean, Roche, Pierre-Alexandre, Roger, Nathalie, Salles, Patricia, Senet, Dominique, Somme, Carmen, Suna-Enache, Alain, Tavildari, Achille, Tchalla, Laurent, Teillet, Lise, Teisseire, Cathy, Théry, Éric, Vérin, Maurice, Viala, Marguerite, Vignon, Olivier, Vittecoq, Eugenia, Volpentesta, Lise, Willems, Alberto, Zalar, Sabrina, Aït, Gilles, Albrand, Jean-Pierre, Aquino, André, Aurengo, Odile, Baugé-Faraldi, Nadine, Bazin, Jean-Louis, Beaudeux, Xavier, Belenfant, Lotfi, Ben Slama, Athanase, Benetos, Jean-Marc, Bereder, Gilles, Berrut, François, Blanchard, Jacques, Boddaert, Christophe, Bouché, Rabia, Boulahssass, Isabelle, Bourdel-Marchasson, Anne, Bruhat, Marie-Andrée, Bruneau, Agnès, Camus, Corinne, Capet, Emmanuelle, Champion, Dominique, Chavanne, Patrick, Chérin, Florence, Chopin, Thierry, Constans, Pascal, Couturier, Véronique, Cressot, Laure, de Decker, Anne-Sophie, De Saint-Léger, Benoit, De Wazières, Philippe, Denormandie, Violaine, Derambure, Laurent, Druesne, Bernard, Durand-Gasselin, Richard, Durant, Marc, Faraldi, Anne-Laure, Fauchais, Audrey, Fel, Éric, François, Florent, François, Éric, Frau, Jacques, Gaillat, Danièle, Ganem-Chabenet, David, Gaucher, Pierre, Gauthier, Gaël, Gendron, Armelle, Gentric, Laura, Goodrich, Isabelle, Got, Etty, Grynberg, Jean-Michel, Guérin, Olivier, Guerin, Karine, Guignery-Kadri, Bernard, Guillot, Victor, Haddad, Pierre, Haond, Cyril, Hazif-Thomas, Jacqueline, Henry, François, Héron, Géraldine, Heurteux, Caroline<ce:sup loc='post">†</ce:sup>, Hommet, Marc, Humbert, Cécile, Hvostoff, Jean-Marc, Jacquot, Claude, Jeandel, Nadir, Kadri, Norelyakin, Kara, Aïda, Kerkeni, Aïni, Khris, Kiyoka, Kinugawa, Rémy, Klein, Emmanuel, Krupka, Marc, Labétoulle, Gilles, Lascault, Julien, Le Guen, Cédric, Le Guillou, Véronique, Lefebvre des Noëttes, Daniel, Letonturier, Caroline, Levasseur, Jean-Pierre, Louvel, Emmanuelle, Magny, Nicolas-Dominique, Manchon, Dominique, Manière, Jean, Mariani, Sophie, Marilier, Thierry, Marquet, Charlotte, Mathon, Emmanuel, Mazen, Anthony, Mézière, Pierre, Michel Jean, Christelle, Mischis-Troussard, Anne-Sophie, Moiziard, A., Morais José, Robert, Moulias, Andy, Musat, Angela, Musat, Cathy, Nabet, Henry, Noguès, Fati, Nourhashémi, Fannie, Onen, Hakki, Onen S., Yves, Otmezguine, Béatrice, Pallot-Prades, Marie-Pierre, Pancrazi, Maxime, Patout, Éric, Pautas, Jérôme, Pellerin, Renaud, Péquignot, Benoît, Pernot, Anne, Petit, Pierre<ce:sup loc='post">†</ce:sup>, Pfitzenmeyer, Benoît, Plaud, Emilie, Puget, François, Puisieux, Lucie, Quibel, Muriel, Rainfray, Cyrielle, Rambaud, Vincent, Rialle, Yves, Rolland, Jean-Nicolas, Royal, Guillaume, Savard, Jean-Pierre, Schuster, Denise, Strubel, Catherine, Terrat, Catherine, Terret, Jean-Étienne, Terrier, Daniel, Tessier, Sarah, Thomas, Thierry, Thomas, Christophe, Trivalle, Lucie, Valembois, Bruno, Vellas, Éric, Verin, Marc, Verny, Marie, Vetel Jean, Pierre, Veyssier, Thomas, Vogel, and Fabienne, Wirotius

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results